Navigation Links
Clinical Renal Trails Do Not Have Sufficient Women Participants

New findings that are being presented during the American Society of Nephrology’s 38th Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania, say that women are not being adequately represented during medical trials // more specifically renal trials. Through analyses of the recently conducted renal trials showed this shortcoming.

It is theorized that this may be the reason why the US Food and Drug Administration (FDA) decided to withdraw many of these drugs from the market. It was found that over the last ten years, 8 out of 10 drugs that were ordered to be withdrawn had serious side effects in women. Dr. Julia Lewis of Vanderbilt University’s Division of Nephrology says that even with the above evidence women were underrepresented at clinical renal trials that were conducted to test the efficacy of certain drugs. She will speak at the symposium and say that pathogenesis of progressive renal disease and hypertension is dependent to some extent on sex hormones and ignoring these potentially harmful effects could adversely impact the health of women. Dr. Lewis is scheduled to speak at length on a topic titled “Gender Issues in Large Clinical Renal Trials,” during a symposium entitled, The Pathophysiology of Progressive Renal Disease and Hypertension: Importance of Gender and Ethnicity.

The meeting is being held from November 8-13 at the Pennsylvania Convention Center in Philadelphia, PA and focuses on distributing the latest research and clinical findings on kidney diseases among 12,000 nephrologists who assemble at the gathering

Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
9. Cancer Clinical Research in India
10. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., December 1, 2015 ... price per sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) ... provides software engineering, infrastructure, as well as operations and sustainment support to the ...
(Date:12/1/2015)... Knoxville, TN (PRWEB) , ... December 01, 2015 ... ... Lessons from the Field for Effective Post-Affiliation Integration ,” addresses a main “pain ... fail to deliver the anticipated results, once a deal is signed. This ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This ... patient care experience, and propose exciting enhancements to the medical landscape. , The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... and Brooke Bennett are collaborating with brands across various categories through traditional and ... figures make up an elite group of Gold Medal Moms who can connect ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... MAPLE GROVE, Minn. and BASEL, ... Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned ... for the further development of a novel, oral small ... cell-adhesion molecule that may be effective in the treatment ... Phase II clinical development. --> ...
(Date:11/30/2015)... TOKYO , 1 décembre 2015 ... plus grande exposition et conférence d,Asie ... médicaux et sur l,industrie manufacturière, se ... du 20 au 22 avril ... - Photo - ...
(Date:11/30/2015)... 1, 2015 ... "Endometriosis - Pipeline Review, H2 2015" market ... therapeutic pipeline of Endometriosis and helps enhance ... strategies to gain competitive advantage. It strengthens ... MOAs to produce first-in-class and best-in-class products. ...
Breaking Medicine Technology: